FDA Sends Letter to Sanofi Aventis Regarding Promotion for BenzaClin

By admin at 4 February, 2010, 6:33 am

ROCKVILLE, Md., Feb.

Go here to see the original:
FDA Sends Letter to Sanofi Aventis Regarding Promotion for BenzaClin

Share and Enjoy:
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks

Related posts:

  1. FDA warns Allergan on Aczone promotion Washington ?An advertisement for Aczone (Allergan), a gel used to...
  2. Sanofi strikes acne-vaccine R&D deal Sanofi Pasteur, the vaccines division of Paris-based drug firm Sanofi,...
  3. Reply to letter by Priori et al commenting on whether Behçet’s syndrome patients with acne and arthritis comprise a true subset No abstract. (Source: Arthritis and Rheumatism) MedWorm Message: Get the...
  4. Cure for acne- Benzaclin The medicine Benzaclin can be used taken as a treatment...
  5. BenzaClin-solution for the stubborn acne BenzaClin has been an active medication for the treatment of...

Categories : Acne News


No comments yet.

Leave a comment